Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:857890-39-2
Molecular Formula:C22H23ClN4O7S
Alias
More Information
4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Aminophenoxy)-7-Methoxy-6-Quinolinecarboxamide Methanesulfonate; E7080 Mesylate; UNII-3J78384F61; Lenvatinib Mesilate (JAN)
Brief Introduction
Lovatinib mesylate is the mesylate of lovatinib. Lovatinib is a multi-target tyrosine kinase inhibitor developed by Japan Weicai company. It has a novel binding mode. In addition to inhibiting other tyrosine kinases related to angiogenesis and carcinogenic signal pathways involved in tumor proliferation, It can also selectively inhibit the kinase activity of vascular endothelial growth factor (VEGF) receptor, such as VEGF-1, VEGF-2 and vegf-3.
Suppliers
View More Vendors (2） >
CAS:1310726-60-3
Molecular Formula:C17H19F3N6O
Alias
More Information
(3S,4R)-3-Ethyl-4-(3H-Imidazo[1,2-a]Pyrrolo[2,3-e]Pyrazin-8-yl)-N-(2,2,2-Trifluoroethyl)-1-Pyrrolidinecarboxamide; 1-Pyrrolidinecarboxamide, 3-Ethyl-4-(3H-Imidazo[1,2-a]Pyrrolo[2,3-e]Pyrazin-8-yl)-N-(2,2,2-Trifluoroethyl)-, (3S,4R)-; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-Imidazo[1,2-a]Pyrrolo[2,3-e]Pyrazin-8-yl)-N-(2,2,2-Trifluoroethyl)Pyrrolidine-1-Carboxamid
Brief Introduction
Upatinib is a Jak1 inhibitor, which has shown good efficacy in clinical trials for the treatment of a variety of autoimmune and inflammatory diseases.
Suppliers
View More Vendors (2） >
CAS:1374248-77-7
Molecular Formula:C29H26F3N5O3
Brief Introduction
Ubrogepant is a new oral calcitonin gene-related peptide receptor (CGRP) antagonist, which has the potential to be used in the study of acute migraine.
Suppliers
View More Vendors (2） >
Allsino Pharmaceutical Co.,Ltd.
-
Pharm Grade
CAS:1289023-67-1
Molecular Formula:C28H28F2N6O3
Alias
More Information
(5S,6S,9R)-5-Nitro-6-(2,3-Difluorophenyl)-6,7,8,9-Tetrahydro-5H-Cyclohepta[b]Pyridin-9-yl 4-(2-oxo-2,3-Dihydro-1H-Imidazo[4,5-b]Pyridin-1-yl)Piperidine-1-Carboxylate; [(5S,6S,9R)-5-Amino-6-(2,3-Difluorophenyl)-6,7,8,9-Tetrahydro-5H-Cyclohepta[b]Pyridin-9-yl] 4-(2-oxo-3H-Imidazo[4,5-b]Pyridin-1-yl)Piperidine-1-Carboxylate; (5S,6S,9R)-5-Amino-6-(2,3-Difluorophenyl)-6,7,8,9-Tetrahydro-5H-Cyclohepta[b]Pyridin-9-yl 4-(2-oxo-2,3-Dihydro-1H-Imidazo[4,5-b]Pyridin-1-yl)Piperidine-1-Carboxylate
Brief Introduction
Rimegepant is a selective and competitive human calcitonin gene-related peptide (CGRP) receptor antagonist.
Suppliers
View More Vendors (2） >
Tables；base；75mg （FDA） ；Lyophilized powder；base；75mg（EMA）
/
Pharm Grade
CAS:868540-17-4
Molecular Formula:C40H57N5O7
Alias
More Information
(2S)-4-Methyl-N-[(2S)-1-[[(2S)-4-Methyl-1-[(2R)-2-Methyloxiran-2-Yl]-1-Oxopentan-2-Yl]Amino]-1-Oxo-3-Phenylpropan-2-Yl]-2-[[(2S)-2-[(2-Morpholin-4-Ylacetyl)Amino]-4-Phenylbutanoyl]Amino]Pentanamide; Kyprolis; Unii-72X6E3J5Ar; Carfilzomib (PR-171); PR-171
Brief Introduction
Carfilzomib is a proteasome inhibitor. Proteasome can decompose proteins that are damaged or no longer needed, thus playing an important role in cell function and growth.
CNY 39.8 Million
19980m²
100-500 People
CRO
CRO
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
|
||||||
| Pharm Grade | - | - |
25kg /
Fibre Drum
|
Main products:
Carfilzomib
/Relugolix
/Ixazomib Citrate
/Apalutamide
/Avatrombopag
/Fulvestrant
/Lenvatinib Mesylate
/Ruxolitinib Phosphate
/Roxadustat
/Brivaracetam
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!